Cite
HARVARD Citation
Urakawa, H. et al. (2020). Clinical value of serum bone resorption markers for predicting clinical outcomes after use of bone modifying agents in metastatic bone tumors: A prospective cohort study. International journal of cancer. 146 (12), pp. 3504-3515. [Online].